Stocks · Health care · Pharmaceutical Preparations

Sagimet Biosciences Inc.

SGMT Clue Score32
United States Fiscal year ends December CIK 0001400118 Results filed 11 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
George Kemble
14 Aug 2026
Director
Sold after exercise
350,987
$10.23
$3.59M
George Kemble
11 Aug 2026
Director
Sold after exercise
20,206
$9.95
$201.15K
New Enterprise Associates 13 LP
18 Jul 2023
10% owner
Sold after exercise
662
$16.00
$10.59K

What was left out

Form 4 filings counted 80
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 3
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 17,749,393
History held since 20 Jul 2023